Whether breast cancer is well-treated or not is related to the staging and typing of breast cancer. Early stage breast cancer, hormone receptor positive breast cancer, and breast cancer with effective biological therapy are all relatively good treatment, while metastasis and triple-negative breast cancer in advanced stage of breast cancer will have poor prognosis.
1. Early stage breast cancer, through radical breast cancer surgery, chemotherapy drugs, endocrine therapy and other methods of treatment, the clinical prognosis is good, the 5-year survival rate reaches 90%, and even achieves the effect of cure, which is a better treatment of breast cancer.
2. Hormone receptor positive, this kind of breast cancer has good prognosis and endocrine therapy is effective.
3. HER2-positive breast cancer, with the use of targeted drugs such as trastuzumab, the 5-year survival rate can even reach 60%~80%, which greatly improves the treatment effect of patients.
4. In advanced breast cancer, distant metastasis has already appeared, and the prognosis is poor.
5. Triple-negative breast cancer, with high malignant degree, 5-year survival rate is only about 10%, with poor prognosis.
Through early detection, early diagnosis, timely surgery, and postoperative comprehensive adjuvant therapy, the prognosis of breast cancer has been significantly improved.